FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033535574> ?p ?o ?g. }

• W3033535574 endingPage "541" @default.
• W3033535574 startingPage "533" @default.
• W3033535574 abstract "The benefits and harms of dual antiplatelet therapy (DAPT) continuation with aspirin and clopidogrel beyond 1 year after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation for high ischemic or bleeding risk patients remain unclear. All consecutive patients undergoing PCI were prospectively included in the Fuwai PCI Registry from January 2013 to December 2013. We evaluated 7521 patients who were at high risk for thrombotic or hemorrhagic complications and were events free at 1 year after the index procedure. TWILIGHT-like patients with high risk of bleeding or ischemic events were defined by clinical and angiographic criteria. The primary ischemic outcome was major adverse cardiac and cerebrovascular events [MACCE] (a composite of all-cause death, myocardial infarction, or stroke). Median follow-up duration was 2.4 years. The risk of MACCE was significantly lower in DAPT>1-year group (n = 5252) than DAPT≤1-year group (n = 2269) (1.5% vs. 3.8%; hazard ratio [HR]: 0.37; 95% confidence interval [CI]: 0.27-0.50; P < .001). This difference was largely driven by a lower risk of all-cause death. In contrast, the risk of Bleeding Academic Research Consortium (BARC) type 2, 3 or 5 bleeding was statistically similar between the two groups (1.0% vs. 1.1%; HR: 0.80; 95% CI: 0.50-1.28; P = .346). Results were consistent after multivariable regression and propensity-score matching. Prolonged DAPT beyond 1 year after DES implantation resulted in a significantly lower rate of atherothrombotic events, including a mortality benefit, with no higher risk of clinically relevant bleeding in TWILIGHT-like patients who were at high-risk for ischemic or bleeding events." @default.
• W3033535574 created "2020-06-12" @default.
• W3033535574 creator A5015631290 @default.
• W3033535574 creator A5035643880 @default.
• W3033535574 creator A5043693897 @default.
• W3033535574 creator A5045349004 @default.
• W3033535574 creator A5050808163 @default.
• W3033535574 creator A5067390667 @default.
• W3033535574 creator A5075782732 @default.
• W3033535574 date "2020-06-05" @default.
• W3033535574 modified "2023-10-02" @default.
• W3033535574 title "Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI" @default.
• W3033535574 cites W146673325 @default.
• W3033535574 cites W1886686547 @default.
• W3033535574 cites W1965953472 @default.
• W3033535574 cites W1972901101 @default.
• W3033535574 cites W2016869940 @default.
• W3033535574 cites W2026518843 @default.
• W3033535574 cites W2046367794 @default.
• W3033535574 cites W2099878930 @default.
• W3033535574 cites W2103293478 @default.
• W3033535574 cites W2103798306 @default.
• W3033535574 cites W2103798714 @default.
• W3033535574 cites W2105210342 @default.
• W3033535574 cites W2122594641 @default.
• W3033535574 cites W2125173296 @default.
• W3033535574 cites W2131110587 @default.
• W3033535574 cites W2138203166 @default.
• W3033535574 cites W2141358924 @default.
• W3033535574 cites W2169252817 @default.
• W3033535574 cites W2180875554 @default.
• W3033535574 cites W2192786504 @default.
• W3033535574 cites W2331820709 @default.
• W3033535574 cites W2335478445 @default.
• W3033535574 cites W2342318753 @default.
• W3033535574 cites W2396902189 @default.
• W3033535574 cites W2515533568 @default.
• W3033535574 cites W2526267487 @default.
• W3033535574 cites W2579869488 @default.
• W3033535574 cites W2752033985 @default.
• W3033535574 cites W2896497827 @default.
• W3033535574 cites W2916912835 @default.
• W3033535574 cites W2921847080 @default.
• W3033535574 cites W2975206218 @default.
• W3033535574 cites W2976166882 @default.
• W3033535574 cites W2987205230 @default.
• W3033535574 cites W5767126 @default.
• W3033535574 doi "https://doi.org/10.1080/09537104.2020.1774052" @default.
• W3033535574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32498587" @default.
• W3033535574 hasPublicationYear "2020" @default.
• W3033535574 type Work @default.
• W3033535574 sameAs 3033535574 @default.
• W3033535574 citedByCount "4" @default.
• W3033535574 countsByYear W30335355742021 @default.
• W3033535574 countsByYear W30335355742022 @default.
• W3033535574 countsByYear W30335355742023 @default.
• W3033535574 crossrefType "journal-article" @default.
• W3033535574 hasAuthorship W3033535574A5015631290 @default.
• W3033535574 hasAuthorship W3033535574A5035643880 @default.
• W3033535574 hasAuthorship W3033535574A5043693897 @default.
• W3033535574 hasAuthorship W3033535574A5045349004 @default.
• W3033535574 hasAuthorship W3033535574A5050808163 @default.
• W3033535574 hasAuthorship W3033535574A5067390667 @default.
• W3033535574 hasAuthorship W3033535574A5075782732 @default.
• W3033535574 hasConcept C126322002 @default.
• W3033535574 hasConcept C127413603 @default.
• W3033535574 hasConcept C141071460 @default.
• W3033535574 hasConcept C164705383 @default.
• W3033535574 hasConcept C17923572 @default.
• W3033535574 hasConcept C207103383 @default.
• W3033535574 hasConcept C2777628954 @default.
• W3033535574 hasConcept C2777849778 @default.
• W3033535574 hasConcept C2780400711 @default.
• W3033535574 hasConcept C2780645631 @default.
• W3033535574 hasConcept C44249647 @default.
• W3033535574 hasConcept C45393284 @default.
• W3033535574 hasConcept C500558357 @default.
• W3033535574 hasConcept C71924100 @default.
• W3033535574 hasConcept C78519656 @default.
• W3033535574 hasConceptScore W3033535574C126322002 @default.
• W3033535574 hasConceptScore W3033535574C127413603 @default.
• W3033535574 hasConceptScore W3033535574C141071460 @default.
• W3033535574 hasConceptScore W3033535574C164705383 @default.
• W3033535574 hasConceptScore W3033535574C17923572 @default.
• W3033535574 hasConceptScore W3033535574C207103383 @default.
• W3033535574 hasConceptScore W3033535574C2777628954 @default.
• W3033535574 hasConceptScore W3033535574C2777849778 @default.
• W3033535574 hasConceptScore W3033535574C2780400711 @default.
• W3033535574 hasConceptScore W3033535574C2780645631 @default.
• W3033535574 hasConceptScore W3033535574C44249647 @default.
• W3033535574 hasConceptScore W3033535574C45393284 @default.
• W3033535574 hasConceptScore W3033535574C500558357 @default.
• W3033535574 hasConceptScore W3033535574C71924100 @default.
• W3033535574 hasConceptScore W3033535574C78519656 @default.
• W3033535574 hasFunder F4320321001 @default.
• W3033535574 hasFunder F4320334969 @default.
• W3033535574 hasIssue "4" @default.
• W3033535574 hasLocation W30335355741 @default.

• next